The Mexico Veterinary Healthcare market is expected to register a CAGR of around 8% during the forecast period, 2018 to 2023. Veterinary medicines are associated with treatment, diagnosis, and prevention of diseases among animals. It covers a variety of animal species, both, in domestic and wild.
A strong bond between human beings and their pets is observed in Mexico. Almost 58% of the households across the country have pets, out of which 80% have dogs and 30% have cats (According to National Institute of Statistics and Geography). 18 million varieties of pet animals live in households, as a part of the family.
The demand for various animal healthcare products and services arise from the will of the pet owners to keep their pets healthy and happy. The propensity to develop diseases or disorders by the animals, owing to harsh conditions also contribute to generating demand. The urban pet owners are the major customers for pet healthcare products, owing to their high income and their accessibility to pet care clinics. Pet ownership in the country is expected to increase further, owing to the growing number of bachelors and childless couples in the country. This high number of unmarried/childless households augment the sales of the pet care market. Moreover, increasing middle class may be able to spend more on pet health.
Considering the trend of increasing pet ownership in the country, the demand for healthcare services and pet owner expenditure for various products and services of veterinary health is also going to increase in the coming years. Additionally, risk of emerging zoonosis, advanced technology leading to innovations and increase awareness about animal health in animal healthcare is also a factor responsible for the growth of Mexico veterinary healthcare market.
Scarcity of arable land and water is one of the major restraining factors for the animal healthcare market in Mexico. According to the World Bank, the country has less than 12% of arable farmland, 57% of pasture and fallow land, 26% for forestry use and the remaining 6% for other uses. More than 70% of the water in Mexico is directed towards farming, leaving a lesser share for industrial and household use. Use of water, other than for these three purposes, is a major concern for the Mexican Government. Scarcity of arable land is the result of a range of human and climatic factors, including soil degradation, climate change, soil constraints, urban encroachment, and unequal land distribution. Widespread degradation and scarcity of land and water resources have placed the key food production systems in the country at risk. Decrease in arable land and water is creating problems in the way of providing resources for animal health. Competition for water between food production and other uses (such as animal husbandry) is intensifying the pressure on the resource allocators in the country. As a result, the production of animals in many regions of the Mexico country is low, which limits the market for animal healthcare products and services with the decreasing veterinary population in the country.
Also, lack of infrastructure and funding, Increasing Costs of Animal Testing and Veterinary Services and use of counterfeit medicines are restraining the growth of Mexico veterinary healthcare market.
The Vaccines segment in Mexico veterinary healthcare market is expected to register a healthy CAGR during the forecasted period due to the presence of good healthcare infrastructure in the country, and it is also experiencing positive trends in the R&D developments.
Major Players: Abaxis Inc., Bayer healthcare, Boehringer Ingelheim, Ceva Animal Health, Inc., Elanco (Eli lilly and company), Merck Animal Health, Virbac Corporation, and Zoetis animal healthcare, amongst others.
Looking to Customize Report?